MACROGENICS INC (MGNX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 60M 120M 180M FY11: 57.2M FY12: 63.8M FY13: 58M FY14: 47.8M FY15: 100.9M FY16: 91.9M FY17: 157.7M FY18: 60.1M FY19: 64.2M FY20: 104.9M FY21: 77.4M FY22: 151.9M FY23: 58.7M FY24: 150M FY25: 149.5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 60M 120M 180M FY19: 64.2M FY20: 104.9M FY21: 74.8M FY22: 148.6M FY23: 58.1M FY24: 149.1M FY25: 149.5M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-210M -140M -70M 0 70M 140M 210M FY11: 5.2M FY12: 8.2M FY13: 366K FY14: -38.3M FY15: -20.2M FY16: -60M FY17: -22.1M FY18: -171.2M FY19: -177.2M FY20: -131.1M FY21: -202.8M FY22: -121.4M FY23: -168.2M FY24: -110.6M FY25: -72.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-210M -140M -70M 0 70M 140M 210M FY11: 6.7M FY12: 8.4M FY13: -261K FY14: -38.3M FY15: -20.1M FY16: -58.5M FY17: -19.6M FY18: -171.5M FY19: -151.8M FY20: -129.7M FY21: -202.1M FY22: -119.8M FY23: -9.1M FY24: -67M FY25: -74.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 1.5M 3M 4.5M FY19: 0 FY20: 0 FY21: 2.7M FY22: 3.4M FY23: 619K FY24: 847K FY25: 0 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-180M -120M -60M 0 60M 120M 180M FY11: 6.8M FY12: -6.6M FY13: -14.2M FY14: -32.8M FY15: -13.7M FY16: -43.7M FY17: 14.4M FY18: -153.2M FY19: -134.3M FY20: -111.9M FY21: -143.8M FY22: -87M FY23: -78.2M FY24: -68.4M FY25: -81M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-210M -140M -70M 0 70M 140M 210M FY11: 6.3M FY12: -7.5M FY13: -17.1M FY14: -36.3M FY15: -22.9M FY16: -55.1M FY17: -15M FY18: -178.2M FY19: -138.6M FY20: -117.8M FY21: -150M FY22: -90.6M FY23: -80M FY24: -72.1M FY25: -83M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY11: 1M FY12: 1.1M FY13: 6.8M FY14: 27.4M FY15: 31.8M FY16: 34.7M FY17: 36.1M FY19: 48.1M FY20: 52.4M FY21: 59.9M FY22: 61.4M FY23: 61.9M FY24: 62.6M FY25: 63.2M FY12 FY14 FY16 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '12: -1.92 Q1 '13: -4.85 Q2 '13: -5.09 Q3 '14: -0.84 Q4 '14: -1.39 Q1 '15: 0.15 Q2 '15: -0.12 Q3 '15: -0.44 Q4 '15: -0.58 Q1 '16: -2.88 Q2 '16: -1.05 Q3 '16: -1.56 Q4 '16: -1.73 Q1 '17: -1.93 Q2 '17: -4.19 Q3 '17: -4.50 Q4 '17: -0.70 Q1 '18: -0.96 Q2 '18: -0.85 Q3 '18: -0.38 Q4 '18: -4.24 Q1 '19: -3.89 Q2 '19: -3.51 Q3 '19: -3.61 Q4 '19: -3.17 Q1 '20: -3.09 Q2 '20: -3.38 Q3 '20: -3.13 Q4 '20: -2.49 Q1 '21: -2.48 Q2 '21: -2.20 Q3 '21: -2.40 Q4 '21: -3.37 Q1 '22: -3.55 Q2 '22: -3.56 Q3 '22: -3.10 Q4 '22: -1.95 Q1 '23: -1.48 Q2 '23: 0.11 Q3 '23: 0.79 Q4 '23: -0.15 Q1 '24: -0.38 Q2 '24: -2.19 Q3 '24: -1.57 Q4 '24: -1.07 Q1 '25: -0.88 Q2 '25: -0.56 Q3 '25: -1.19 Q4 '25: -1.17 Q1 '26: -1.10 Q2 '26: -0.22 Q1 '13 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.